Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT India 2025

Management in the ICU BEFORE high-risk PCI and/or shock

Presenter: Vijay Chilakamarri

July 25, 2025

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation THT Abstracts 2024

Beyond Supine Pulmonary Artery Pressures

Presenter: Marat Fudim

March 05, 2024

Presentation ACC 2023

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

Presenter: John P. Boehmer

March 05, 2023

Presentation Miami Valves 2023

Gender and Racial Disparities in SCD Prevention

Presenter: Litsa K. Lambrakos

February 03, 2023

Presentation ACC 2022

A Cluster-Randomized PRagmatic Trial Aimed At ImprOving Use Of Guideline Directed Medical Therapy In OutPatienTs With Heart Failure: PROMPT-HF

Presenter: Tariq Ahmad

April 04, 2022

Presentation ACC 2022

SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure

Presenter: Justin Ezekowitz

April 04, 2022

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Presentation AHA 2018

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Presenter: Eric J Velazquez

November 12, 2018

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presentation ESC 2018

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

Presentation ECHO 2018

Echocardiographic Approach To Congenital Heart Disease: The Postoperative Adult

Presenter: Karen Stout

April 20, 2018

Presentation ECHO 2018

Evaluation of Pregnant Patients with Heart Disease

Presenter: Karen Stout

April 20, 2018

Presentation TVT 2017

CARILLON: Eligibility and Outcomes, and RCT Design

Presenter: Saibal Kar, Steven L. Goldberg, MD

June 15, 2017

Presentation ESC 2016

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Presenter: Patrizio Lancellotti

August 27, 2016

Presentation

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Presenter: Yariv Gerber

March 31, 2016

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

Presentation ECHO 2015

Case Presentation 69 Year Old Man with CHF and TVR

Presenter: Fletcher A. Miller

April 27, 2015

Presentation ECHO 2015

Cardiomyopathy - Diastology Cases(1)

Presenter: Mario J Garcia

April 27, 2015

Presentation CATCH-UP 2015

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Presenter: Silviu Itescu

April 24, 2015

Advertisement

Management in the ICU BEFORE high-risk PCI and/or shock

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Main Results From The Step-hfpef Dm Trial

Beyond Supine Pulmonary Artery Pressures

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

Gender and Racial Disparities in SCD Prevention

A Cluster-Randomized PRagmatic Trial Aimed At ImprOving Use Of Guideline Directed Medical Therapy In OutPatienTs With Heart Failure: PROMPT-HF

SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Echocardiographic Approach To Congenital Heart Disease: The Postoperative Adult

Evaluation of Pregnant Patients with Heart Disease

CARILLON: Eligibility and Outcomes, and RCT Design

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Case Presentation 69 Year Old Man with CHF and TVR

Cardiomyopathy - Diastology Cases(1)

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content